Boca Pharmacal Inc. March 9 announced that the Food and Drug Administration has approved its generic version of King Pharmaceuticals Inc.'s Tapazole (methimazole) 5 mg and 10 mg tablets.
Tapazole is indicated to treat hyperthyroidism, the company said.
Boca Pharmacal, based in Coral Springs, Fla., said it expects to have multiple approvals in 2012.
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.